'Fake' batch of Ozempic recalled
Malta Medicines Authority warns patients to stop using this particular pack
A particular batch of Ozempic has been recalled on Friday on suspicion it may have been “falsified”, the health authorities have warned.
In a statement, the Malta Medicines Authority said that one pack of Ozempic 1mg solution for injection in pre-filled pen from batch number PP5N682::RN287 “is suspected to be possibly falsified”.
The recall applies to this batch only with expiry date 02/2027.
The MMA was alerted by Ozempic’s marketing authorisation holder Novo Nordisk of the issue.
Patients who have this particular batch should stop using the product and return the pack to the pharmacy from where it was purchased. They should speak to their pharmacists or doctor to seek continuation of treatment.
The MMA and the Superintendent of Public Health are “working with relevant stakeholders to safeguard any possible risk to public health”.
This is not the first time that Novo Nordisk has had to issue such a warning about fake batches of Ozempic. In April, it found several hundred units of counterfeit Ozempic had been distributed outside its authorised supply chain in the United States.
Ozempic, known generically as semaglutide, is used in adults with type 2 diabetes. It is a weekly injection that helps lower blood sugar by helping the pancreas make more insulin.
It hit the headlines in recent years as a weight loss aid despite it not being offically approved for that use.